Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis

Conditions:   Amyloidosis;   Light Chain (AL) Amyloidosis Interventions:   Drug: Bendamustine Hydrochloride;   Drug: Isatuximab Sponsors:   Tufts Medical Center;   Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials